LT3630977T - Baltymų, kurių sudėtyje yra negamtinių aminorūgščių, gamybos skatinimo būdai ir kompozicijos - Google Patents
Baltymų, kurių sudėtyje yra negamtinių aminorūgščių, gamybos skatinimo būdai ir kompozicijosInfo
- Publication number
- LT3630977T LT3630977T LTEPPCT/US2018/035764T LTUS2018035764T LT3630977T LT 3630977 T LT3630977 T LT 3630977T LT US2018035764 T LTUS2018035764 T LT US2018035764T LT 3630977 T LT3630977 T LT 3630977T
- Authority
- LT
- Lithuania
- Prior art keywords
- compositions
- methods
- amino acid
- natural amino
- protein production
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 230000014616 translation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
- C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762514754P | 2017-06-02 | 2017-06-02 | |
| PCT/US2018/035764 WO2018223108A1 (en) | 2017-06-02 | 2018-06-02 | Methods and compositions for promoting non-natural amino acid-containing protein production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3630977T true LT3630977T (lt) | 2024-04-25 |
Family
ID=62749186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/US2018/035764T LT3630977T (lt) | 2017-06-02 | 2018-06-02 | Baltymų, kurių sudėtyje yra negamtinių aminorūgščių, gamybos skatinimo būdai ir kompozicijos |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11851662B2 (lt) |
| EP (2) | EP3630977B1 (lt) |
| JP (2) | JP7245786B2 (lt) |
| KR (3) | KR102705871B1 (lt) |
| CN (2) | CN117286182A (lt) |
| AU (1) | AU2018275152A1 (lt) |
| BR (1) | BR112019025476A2 (lt) |
| CA (1) | CA3065137A1 (lt) |
| DK (1) | DK3630977T5 (lt) |
| ES (1) | ES2978044T3 (lt) |
| FI (1) | FI3630977T3 (lt) |
| HR (1) | HRP20240344T1 (lt) |
| IL (1) | IL270906A (lt) |
| LT (1) | LT3630977T (lt) |
| MX (2) | MX2019014286A (lt) |
| MY (1) | MY202215A (lt) |
| PL (1) | PL3630977T3 (lt) |
| PT (1) | PT3630977T (lt) |
| RS (1) | RS65370B1 (lt) |
| SI (1) | SI3630977T1 (lt) |
| WO (1) | WO2018223108A1 (lt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019245444A1 (en) | 2018-03-29 | 2020-10-01 | Ambrx, Inc. | Humanized anti-prostate-specific membrane antigen (PSMA) antibody drug conjugates |
| PL3849614T3 (pl) | 2018-09-11 | 2024-04-22 | Ambrx, Inc. | Koniugaty polipeptydu interleukiny-2 i ich zastosowania |
| JP7560459B2 (ja) * | 2018-12-21 | 2024-10-02 | ジェネンテック， インコーポレイテッド | アポトーシスに耐性のある細胞株を使用してポリペプチドを生成する方法 |
| CN111117944B (zh) * | 2019-11-22 | 2022-05-24 | 中农威特生物科技股份有限公司 | 一种用于规模化悬浮培养的抗凋亡mdck宿主细胞株及其建立方法 |
| CN112375774A (zh) * | 2020-10-26 | 2021-02-19 | 浙江新码生物医药有限公司 | 一种重组蛋白表达用工程菌株的构建方法 |
| CN112575005A (zh) * | 2021-01-04 | 2021-03-30 | 昆明理工大学 | 一种提高烟草重金属镉胁迫抗性和降低镉富集的方法 |
| AU2023218678A1 (en) | 2022-02-09 | 2024-08-01 | Daiichi Sankyo Company, Limited | Environmentally responsive masked antibody and use thereof |
| WO2023202967A1 (en) * | 2022-04-19 | 2023-10-26 | F. Hoffmann-La Roche Ag | Improved production cells |
| WO2024155627A1 (en) | 2023-01-16 | 2024-07-25 | Ambrx, Inc. | Anti-cd70 antibody-drug conjugates |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002303431C1 (en) | 2001-04-19 | 2008-03-06 | The Regents Of The University Of California | Methods and composition for the production of orthoganal tRNA-aminoacyltRNA synthetase pairs |
| EP1583816A4 (en) | 2002-12-22 | 2007-06-13 | Scripps Research Inst | PROTEIN NETWORKS |
| CN101160525A (zh) | 2003-06-18 | 2008-04-09 | 斯克利普斯研究院 | 非天然活性氨基酸遗传密码增加 |
| EP2410331B1 (en) | 2003-06-18 | 2015-09-23 | The Scripps Research Institute | Aminoacyl-tRNA synthetase for aminoacylation tRNA with unnatural amino acids |
| CA2590429C (en) | 2004-12-22 | 2014-10-07 | Ambrx, Inc. | Compositions of aminoacyl-trna synthetase and uses thereof |
| CN102703446B (zh) | 2005-08-18 | 2014-05-28 | Ambrx公司 | tRNA组合物和其用途 |
| PT2339014E (pt) * | 2005-11-16 | 2015-10-13 | Ambrx Inc | Métodos e composições compreendendo aminoácidos não-naturais |
| CA2882445A1 (en) | 2005-12-14 | 2007-06-21 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| WO2008030613A2 (en) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Hybrid suppressor trna for vertebrate cells |
| ES2465473T3 (es) | 2006-09-08 | 2014-06-05 | Ambrx, Inc. | Transcripción de arnt supresor en células de vertebrado |
| CN101528914B (zh) * | 2006-09-08 | 2014-12-03 | Ambrx公司 | 通过脊椎动物细胞位点特异性并入非天然氨基酸 |
| AU2007333010A1 (en) * | 2006-10-18 | 2008-06-19 | The Scripps Research Institute | Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| US8183037B2 (en) | 2007-04-13 | 2012-05-22 | The Salk Institute For Biological Studies | Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal tRNA/synthetase pairs |
| TW200914043A (en) | 2007-04-30 | 2009-04-01 | Mj Biolog Inc | PRRSV GP5 based compositions and methods |
| GB0721291D0 (en) * | 2007-10-30 | 2007-12-12 | Medical Res Council | Methods and compositions |
| US8597912B2 (en) | 2008-06-10 | 2013-12-03 | Sangamo Biosciences, Inc. | Methods and compositions for generation of Bax-and Bak-deficient cell lines |
| WO2010141851A1 (en) * | 2009-06-05 | 2010-12-09 | Salk Institute For Biological Studies | Improving unnatural amino acid incorporation in eukaryotic cells |
| US20150018530A1 (en) | 2012-02-29 | 2015-01-15 | Ambrx, Inc. | Novel Prodrug Containing Molecule Compositions and Their Uses |
| US10800856B2 (en) | 2012-06-07 | 2020-10-13 | Ambrx, Inc. | Prostate-specific membrane antigen antibody drug conjugates |
| AU2013274078A1 (en) | 2012-06-14 | 2015-01-29 | Ambrx, Inc. | Anti-PSMA antibodies conjugated to nuclear receptor ligand polypeptides |
| EP2861262B1 (en) | 2012-06-19 | 2018-11-28 | Ambrx, Inc. | Anti-cd70 antibody drug conjugates |
| GB201419109D0 (en) * | 2014-10-27 | 2014-12-10 | Medical Res Council | Incorporation of unnatural amino acids into proteins |
-
2018
- 2018-06-02 PL PL18734359.5T patent/PL3630977T3/pl unknown
- 2018-06-02 DK DK18734359.5T patent/DK3630977T5/da active
- 2018-06-02 CN CN202311164969.8A patent/CN117286182A/zh active Pending
- 2018-06-02 PT PT187343595T patent/PT3630977T/pt unknown
- 2018-06-02 AU AU2018275152A patent/AU2018275152A1/en active Pending
- 2018-06-02 MX MX2019014286A patent/MX2019014286A/es unknown
- 2018-06-02 SI SI201831076T patent/SI3630977T1/sl unknown
- 2018-06-02 EP EP18734359.5A patent/EP3630977B1/en active Active
- 2018-06-02 FI FIEP18734359.5T patent/FI3630977T3/fi active
- 2018-06-02 MY MYPI2019007098A patent/MY202215A/en unknown
- 2018-06-02 KR KR1020247014001A patent/KR102705871B1/ko active IP Right Grant
- 2018-06-02 WO PCT/US2018/035764 patent/WO2018223108A1/en active Application Filing
- 2018-06-02 BR BR112019025476-5A patent/BR112019025476A2/pt unknown
- 2018-06-02 US US16/958,152 patent/US11851662B2/en active Active
- 2018-06-02 EP EP24158417.6A patent/EP4382124A3/en active Pending
- 2018-06-02 CA CA3065137A patent/CA3065137A1/en active Pending
- 2018-06-02 KR KR1020197038544A patent/KR102662379B1/ko active IP Right Grant
- 2018-06-02 CN CN201880049275.0A patent/CN110959041B/zh active Active
- 2018-06-02 RS RS20240405A patent/RS65370B1/sr unknown
- 2018-06-02 HR HRP20240344TT patent/HRP20240344T1/hr unknown
- 2018-06-02 ES ES18734359T patent/ES2978044T3/es active Active
- 2018-06-02 LT LTEPPCT/US2018/035764T patent/LT3630977T/lt unknown
- 2018-06-02 JP JP2019565862A patent/JP7245786B2/ja active Active
- 2018-06-02 KR KR1020247030044A patent/KR20240140174A/ko active Search and Examination
-
2019
- 2019-11-25 IL IL270906A patent/IL270906A/en unknown
- 2019-11-28 MX MX2023004927A patent/MX2023004927A/es unknown
-
2023
- 2023-03-13 JP JP2023038441A patent/JP2023075254A/ja active Pending
- 2023-11-10 US US18/506,836 patent/US20240167044A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL270906A (en) | Methods and preparations for promoting the production of a protein containing an unnatural amino acid | |
| HK1244185A1 (zh) | 用於生成卵清蛋白的方法和組合物 | |
| IL262321A (en) | Preparations and methods for selective protein expression | |
| SI3240895T1 (sl) | Sestavki in postopki za glikozilacijo proteinov | |
| GB201419109D0 (en) | Incorporation of unnatural amino acids into proteins | |
| IL249131A0 (en) | A method for reducing the immunogenicity of protein and peptide | |
| HK1252648A1 (zh) | 氨基酸增補 | |
| IL253971A0 (en) | A method for purifying fusion proteins-albumin | |
| IL252902A0 (en) | Amino acid and peptide conjugates and their uses | |
| EP3377633C0 (en) | PRODUCTION OF RECOMBINANT PROTEINS | |
| HK1255012A1 (zh) | 含氨基酸的組合物 | |
| SI3289088T1 (sl) | Odklop rasti in proizvodnja proteina | |
| ZA201806409B (en) | Novel nanoemulsions comprising n-acyl amino acid salt and process for making | |
| EP2968469A4 (en) | PEPTIDES COMPRISING NON-ENDOGENIC AMINO ACIDS AND METHODS OF MAKING AND USING SAME | |
| HK1250726A1 (zh) | 含有氨基酸及環狀二肽的組合物 | |
| SG11202006140TA (en) | Process for providing pegylated protein composition | |
| EP3345003A4 (en) | IDENTIFICATION OF PROTEINS IN THE ABSENCE OF PEPTIDE IDENTIFICATION | |
| SG11202005952TA (en) | Process for providing pegylated protein composition | |
| SG11202005990RA (en) | Process for providing pegylated protein composition | |
| EP3665186C0 (en) | RECOMBINANT PROTEIN VP60 AND METHOD FOR ITS PRODUCTION AND PURIFICATION | |
| EP3665185C0 (en) | RECOMBINANT PROTEIN VP60 AND PROCEDURE FOR ITS PRODUCTION AND PURIFICATION | |
| GB201621512D0 (en) | Unnatural amino acids | |
| GB201622073D0 (en) | Improved recombinant protein production system |